Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Avantor Inc is a specialty chemicals business based in the US. Avantor shares (AVTR) are listed on the NYSE and all prices are listed in US Dollars. Avantor employs 13,500 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $31.61 |
|---|---|
| 52-week range | $28.64 - $44.37 |
| 50-day moving average | $31.06 |
| 200-day moving average | $35.90 |
| Wall St. target price | $40.94 |
| PE ratio | 35.0225 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.89 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $31.61 from 2022-07-01
| 1 week (2022-06-27) | -1.19% |
|---|---|
| 1 month (2022-05-31) | N/A |
| 3 months (2022-03-31) | N/A |
| 6 months (2022-01-04) | -19.30% |
| 1 year (2021-07-02) | -10.61% |
|---|---|
| 2 years (2020-07-02) | 80.32% |
| 3 years (2019-07-03) | 66.90% |
| 5 years (2017-06-30) | N/A |
Valuing Avantor stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avantor's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Avantor's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 35x. In other words, Avantor shares trade at around 35x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Avantor's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.5 billion.
The EBITDA is a measure of a Avantor's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $7.6 billion |
|---|---|
| Operating margin TTM | 14.79% |
| Gross profit TTM | $2.5 billion |
| Return on assets TTM | 5.92% |
| Return on equity TTM | 16.72% |
| Profit margin | 7.93% |
| Book value | $5.50 |
| Market capitalisation | $19 billion |
TTM: trailing 12 months
We're not expecting Avantor to pay a dividend over the next 12 months.
Over the last 12 months, Avantor's shares have ranged in value from as little as $28.635 up to $44.37. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Avantor's is 1.5305. This would suggest that Avantor's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.